Analysis of human ccRCC tumor #22 revealed the same pattern, with the Ki67 positivity rate more than seven times higher in the VHL-positive (26.6%) than the VHL-negative tumor areas (1.4%) (Fig. 3f). This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.